Study

EORTC-30993

A randomized phase II trial of sequential chemo-immunotherapy versus immunotherapy alone in carcinoma in situ of the urinary bladder.

Study documentation Back to result

Trial Status

All trial activities ended

Dates

Date of activation: 07-Jun-2001
Date Step1 close: 21-Feb-2005

Data management at EORTC

Yes

Design

Phase 2
Randomized open label

Targeted Sample size

EORTC Groups: 90

Protocol summary

http://clinicaltrials.gov/study/NCT00023842

NCT number

NCT00023842